Brain-Mapping Device US FDA-Cleared To Help Surgeons Better Visualize Surgical Area

The neurosurgical planning software is meant to help surgeons see critical parts of the brain to prevent causing unnecessary harm to patients undergoing brain surgery.

A brain wrapped with a simple road map texture

Omniscient Neurotechnology’s Quicktome device has been cleared in the US to help surgeons map a patient’s brain before operating on them. The neurosurgical planning software is meant to help reduce surgical uncertainty and prevent surgeons from cutting into critical areas of the brain that could harm the patient.

The company announced on 21 July that it received 510(k) clearance for the Quicktome device from the Food and Drug...

Welcome to Medtech Insight

Create an account to read this article

More from Business

Veris Health Expands Oncology Monitoring Platform, Plans Implantable Sensor By 2026

 
• By 

Banking on new billing codes for remote services, PAVmed’s Veris Health is expanding its oncology remote monitoring platform with Ohio State’s cancer center and developing an implantable physiological monitor to provide clinicians with continuous insights between treatment visits.

Ready For Lift-Off: India’s Medtech Industry Sees Rapid Advancement

 
• By 

C-suite executives from Stryker, Intuitive Surgical and Fresenius passed a mainly upbeat verdict on the Indian medtech market and industry.

Zimmer Biomet-Monogram Merger: After Clearances, First CVR Milestone Approaching In January 2026

 
• By 

After a slight delay in closing the deal, Zimmer now has Monogram in-house. For shareholders hoping for CVR payouts, the first one looks fairly achievable, the rest increasingly less so. The vagaries of FDA clearance and market performance offer significant challenges to the new robotics powerhouse.

Abbott Eyes Strong US Diabetes Growth In 2026, Diagnostics Recovery As China Headwinds Ease

 
• By 

Abbott CEO Robert Ford said the diagnostics segment – pressured this year by China’s VBP and DRG reforms – is showing early signs of recovery, while the company’s operations in the US, Europe, and Latin America continue to grow at a healthy pace.

More from Medtech Insight

Veris Health Expands Oncology Monitoring Platform, Plans Implantable Sensor By 2026

 
• By 

Banking on new billing codes for remote services, PAVmed’s Veris Health is expanding its oncology remote monitoring platform with Ohio State’s cancer center and developing an implantable physiological monitor to provide clinicians with continuous insights between treatment visits.

Ready For Lift-Off: India’s Medtech Industry Sees Rapid Advancement

 
• By 

C-suite executives from Stryker, Intuitive Surgical and Fresenius passed a mainly upbeat verdict on the Indian medtech market and industry.

Medicare’s TCET Pathway Wins Acclaim From Early Users, Even As ‘Messy Middle’ Persists

 

Some of the first manufacturers to receive Medicare coverage for their breakthrough devices through the Transitional Coverage for Emerging Technologies pathway praise CMS’ engagement and timelines in the process, despite some challenges around post-launch data collection.